This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Pompe disease is a rare, life-threatening genetic disorder caused by GAA enzyme deficiency, leading to glycogen buildup and muscle cell destruction. It presents on a spectrum, from infantile-onset…
Neil K. Warma, President & CEO, Opexa Therapeutics, delves into Opexa’s Phase 2B ABILI-T Clinical Trial for secondary progressive multiple sclerosis (MS) that expects to yield top-line results in 2016. Previous studies showed that with…
Jose Cavazos, MD, Professor of Medicine – Neurology & Physiology, Associate Professor of Pharmacology at University of Texas Health Science Center at San Antonio, discusses responsive neurological stimulation…
Selim R. Benbadis, MD, Director, Comprehensive Epilepsy Program, University of South Florida and Tampa General Hospital, discusses a common problem in reading EEGs: over-reading or misreading a normal…
Jason Silva, host of National Geographic’s Brain Games, introduces a new campaign, MS Visionaries, which will be featured in the Yahoo Health Portal. The program highlights visionaries who are…
Neil K. Warma, President & CEO, Opexa Therapeutics, discusses how Opexa’s research into the first personalized therapy for patients with multiple sclerosis (MS) could have much broader applications as a platform technology.…
Neil K. Warma, President & CEO, Opexa Therapeutics, gives background on what he means by “personalized therapy”. In contrast to the “sledgehammer effect” that current oral multiple sclerosis (MS) have…
Neil K. Warma, President & CEO, Opexa Therapeutics, explains Opexa’s goal to create the first personalized therapy for patients with multiple sclerosis. He discusses the ABILI-T Phase 2 Clinical…
People who develop fibromyalgia may complain of fatigue, memory problems and disturbances with sleep and mood. Fibromyalgia is often hard to diagnose and treat because there is not…
Ajay Verma, MD, PhD, VP of Translational Neurology at Biogen Inc., explains that we may have some of the technologies to answer the most challenging question of how…
Patients with critical illness often experience pain and other stresses that put them at risk for developing psychiatric illnesses. These include anxiety, post-traumatic stress disorder and depression. A…
